GALLERANI, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 2.282
EU - Europa 1.016
AS - Asia 485
AF - Africa 5
SA - Sud America 1
Totale 3.789
Nazione #
US - Stati Uniti d'America 2.273
PL - Polonia 342
IT - Italia 308
CN - Cina 198
SG - Singapore 141
UA - Ucraina 85
DE - Germania 72
TR - Turchia 72
GB - Regno Unito 68
ID - Indonesia 37
SE - Svezia 36
BE - Belgio 33
FI - Finlandia 31
VN - Vietnam 17
IR - Iran 10
CA - Canada 8
FR - Francia 8
LT - Lituania 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
NL - Olanda 5
CH - Svizzera 4
IE - Irlanda 4
RO - Romania 3
AT - Austria 2
HK - Hong Kong 2
IN - India 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
ES - Italia 1
IL - Israele 1
KH - Cambogia 1
MN - Mongolia 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 3.789
Città #
Warsaw 342
Fairfield 254
Woodbridge 228
Ann Arbor 210
Houston 188
Ferrara 177
Chandler 176
Ashburn 143
Santa Clara 117
Jacksonville 114
Singapore 114
Seattle 108
Cambridge 107
Wilmington 103
Beijing 44
Izmir 38
Jakarta 37
Shanghai 34
Brussels 33
New York 33
Bologna 31
Nanjing 31
Princeton 31
San Diego 31
Boardman 21
Milan 20
Dong Ket 17
Los Angeles 15
Rome 12
Shenyang 12
Helsinki 10
Munich 10
Hebei 9
Nanchang 9
Dearborn 8
Augusta 7
Changsha 7
London 7
Modena 7
Des Moines 6
Ferrara di Monte Baldo 6
Jiaxing 6
Leawood 6
Mountain View 6
Redwood City 6
Washington 6
Ardabil 5
Bremen 5
Brno 5
Jinan 5
Ningbo 5
Norwalk 5
Addison 4
Dublin 4
Indiana 4
Ottawa 4
Sharif 4
Zurich 4
Amsterdam 3
Auburn Hills 3
Falkenstein 3
Falls Church 3
Frankfurt am Main 3
Kunming 3
Orange 3
Portsmouth 3
San Mateo 3
Tianjin 3
Haikou 2
Hangzhou 2
Hong Kong 2
Massapequa 2
New Bedfont 2
Parma 2
Phoenix 2
Redmond 2
San Francisco 2
Seoul 2
Taizhou 2
Tappahannock 2
Toronto 2
Vienna 2
Acton 1
Aprilia 1
Bari 1
Beirã 1
Bengaluru 1
Borgo Valsugana 1
Bretagne 1
Bucharest 1
Canonsburg 1
Changchun 1
Chengdu 1
Chiswick 1
Clifton 1
Dubai 1
Duluth 1
Edinburgh 1
Farmville 1
Fort Collins 1
Totale 3.067
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 265
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 259
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 205
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 173
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 161
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 161
NO Photoreleaser-Deoxyadenosine and -Bile Acid Derivative Bioconjugates as Novel Potential Photochemotherapeutics 156
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 149
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 147
Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery 146
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 142
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 137
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 136
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 135
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 134
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 125
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 124
Synthesis, characterization and antiproliferative activity of amino- and DMSO complexes of platinum(II) containing L-carnitine 119
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 117
Comparative antiproliferative activities of wood and seeds essential oils of Juniperus oxycedrus L. against K562 human chronic myelogenus leukemia cells. 106
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 102
Encapsulation of dedifferentiated nasal septal chondrocytes in alginate based scaffolds for cartilage tissue engineering 99
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation 87
Hpv-specific systemic antibody responses and memory b cells are independently maintained up to 6 years and in a vaccine-specific manner following immunization with cervarix and gardasil in adolescent and young adult women in vaccination programs in Italy 54
Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine 54
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 51
null 49
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8+ T Cells in Elderly Humans 48
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 47
null 43
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 39
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 37
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 28
Design, Synthesis and Evaluation of New Multifunctional Benzothiazoles as Photoprotective, Antioxidant and Antiproliferative Agents 27
ANTIRETROVIRAL THERAPY PARTIALLY RESTORES PHENOTYPIC AND METABOLIC IMMUNOSENESCENCE FEATURES OF T CELLS IN HIV INFECTED INDIVIDUALS 27
Age differentially impacts adaptive immune responses induced by adenoviral versus mRNA vaccines against COVID-19 8
Totale 3.897
Categoria #
all - tutte 18.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 0 0 0 0 0 75 65 63 68 66 38 26
2020/2021701 52 32 24 43 56 50 34 89 39 149 84 49
2021/2022378 18 43 10 22 9 15 41 23 25 34 30 108
2022/2023417 41 31 22 59 54 46 35 45 48 2 23 11
2023/2024277 36 38 10 11 14 57 18 16 3 5 11 58
2024/2025423 32 23 96 73 105 94 0 0 0 0 0 0
Totale 3.897